TheraVet is a vet biotech company headquartered in Belgium (Jumet, Wallonia) with an US-based subsidiary.
TheraVet's mission is to develop innovative, safe and effective treatments to improve the well-being and quality of life of companion animals suffering from osteoarticular diseases.
TheraVet's main targets (indications & applications) are osteoarthritis, ligament & tendon injuries and bone surgery in cats and dogs as well as horses.
TheraVet works in close collaboration with key opinion leaders in Belgium and abroad (France, Switzerland, United Kingdom & United States) to better address the ever-increasing needs of veterinary medicine.
TheraVet is committed to develop new treatments specifically adapted to pets.
The strong experience of the team ensures a rigorous development process addressing the current market and regulatory trends.